喜保宁的价格和购买途径、医保信息?
Vigabatrin is a drug used to treat epilepsy and infantile spasms. The Turkish version of the drug sells for about $1,125. The channels for obtaining Vigabatrin include purchasing abroad, online pharmacies, adding patient groups, overseas medical service institutions, etc. As of January 2024, Vigabatrin has not been included in medical insurance, and patients need to purchase it at their own expense.
The new anti-epileptic drug - Vigabatrin
is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA), which produces anti-epileptic effects by irreversibly inhibiting the degrading enzyme GABA-aminase. This results in increased central nervous system (CNS) GABA levels. Vigabatrin is one of the few anti-epileptic drugs that has a specific targeting mechanism and has subsequently been shown to act through this mechanism.
Vigabatrin was approved in the United States in 2009 and is currently used as an adjuvant treatment for patients ≥10 years old with refractory complex partial seizures (rCPS) who have failed to respond to multiple alternative treatments, and as a monotherapy for patients 1 month to 2 years old with infantile spasms (IS).
The new anti-epileptic drug Vigabatrin has remarkable clinical effects. When used in combination with traditional anti-epileptic drugs, it can reduce the number of seizures in 50% of patients by half.
Vigabatrin medical insurance information
As of January 22, 2024, Vigabatrin has not been listed in China, and therefore has not been included in medical insurance.
Vigabatrin price
Since Vigabatrin has not yet been launched in China, there is no domestic price information for this drug. It is understood that the Turkish version of Vigabatrin from France's Sanofi is available in a box of 500 mg x 100 capsules, with a reference price of approximately $1,125.
Vigabatrin drug purchase channels
1. Purchasing drugs abroad: Vigabatrin is marketed in the United States, Japan, etc., so patients can purchase it at local medical institutions or pharmacies with a doctor's prescription.
2. Online pharmacies: There are many online pharmacies on the Internet that provide drugs, and some can accept international orders and mail drugs. But before buying, you should make sure the website is legitimate.
3. International drug agents: Some companies specialize in international drug agents and can help patients purchase Vigabatrin from other countries.
4. Drug import services: Some services specialize in drug import, and they can help patients bring drugs from other countries to where they are.
5. Going abroad for medical treatment: For example, when going to countries such as Japan, patients can consult professional neurologists in public or private hospitals. The doctor will decide whether to prescribe Vigabatrin based on the patient's condition and treatment needs. After issuing a prescription, the patient can go to the pharmacy department of the hospital to receive the drug.
6. Ask patients: Patients can also add patients to the patient group, ask if anyone has purchased Vigabatrin in the patient group, and ask them about purchasing channels.
7. Overseas medical service institutions: Patients can also choose domestic reliable, professional and formal overseas medical service institutions to obtain Vigabatrin, which can ensure the quality of the drug.
8. International purchasing: For situations where Vigabatrin is unavailable, patients can also consider international purchasing. This includes, for example, bringing it from other countries through relatives or friends. However, when purchasing drugs internationally, you need to pay attention to the quality and legality of the drugs, and whether they comply with international regulations.
It is important to note that when purchasing Vigabatrin or any prescription drug, patients should ensure that they follow their doctor's recommendations and purchase from a trusted supplier to ensure the safety and effectiveness of the drug.
Summary
Vigabatrin is a new anti-epileptic drug. After purchasing the drug, patients should strictly follow the doctor’s recommendations for treatment. During the treatment period, attention should be paid to observing adverse drug reactions and therapeutic effects, and conducting regular reviews so that doctors can treat patients according to their response to the drug.
Recommended hot articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)